Diabetes prevalence continues to climb with the aging population. Type 2 diabetes (T2D),
which constitutes most cases, is metabolically acquired. Diabetic peripheral neuropathy …

Neuropathy will afflict over half of the estimated 460 million people worldwide who have
diabetes, 303 of whom approximately onethird will also develop neuropathic pain. 2 The …

Ischemic cardiomyopathy (ICM) is a special type of coronary heart disease or an advanced
stage of the disease, which is related to the pathological mechanism of primary dilated …

Diabetes mellitus (DM) significantly increases the risk of heart disease, and DM-related
healthcare expenditure is predominantly for the management of cardiovascular …

Background Platinum based agents—cisplatin and carboplatin in combination with taxanes
are used for the treatment of ovarian cancer (OC) patients. However, the majority of OC …

Diabetes mellitus is one of the major non-communicable diseases accounting for millions of
death annually and increasing economic burden. Hyperglycemic condition in diabetes …

Mitochondrial dysfunction is the main cause of damage to the pathological mechanism of
ischemic cardiomyopathy. In addition, mitochondrial dysfunction can also affect the …

The use of mesenchymal stem cells (MSCs) has become a new strategy for treating diabetic
kidney disease (DKD). However, the role of placenta derived mesenchymal stem cells (P …

As a major late complication of diabetes, diabetic peripheral neuropathy (DPN) is the
primary reason for amputation. Nevertheless, there are no wonder drugs available …

With the continuous improvement of living standards but the lack of exercise, aging-
associated metabolic diseases such as obesity, type 2 diabetes mellitus (T2DM), and non …